CanSino Biologics, Inc. (CASBF)
3.90
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
CanSino Biologics Net Income (Quarterly) : -5.838M for March 31, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -5.838M |
| December 31, 2025 | 1.894M |
| September 30, 2025 | 3.902M |
| June 30, 2025 | -0.2682M |
| March 31, 2025 | -1.587M |
| December 31, 2024 | -21.77M |
| September 30, 2024 | 0.4136M |
| June 30, 2024 | -7.633M |
| March 31, 2024 | -24.33M |
| December 31, 2023 | -70.89M |
| September 30, 2023 | -23.84M |
| June 30, 2023 | -158.50M |
| March 31, 2023 | -24.88M |
| December 31, 2022 | -66.90M |
| September 30, 2022 | -73.67M |
| June 30, 2022 | -14.88M |
| Date | Value |
|---|---|
| March 31, 2022 | 18.00M |
| December 31, 2021 | 89.65M |
| September 30, 2021 | 61.33M |
| June 30, 2021 | 147.49M |
| March 31, 2021 | -2.431M |
| December 31, 2020 | -33.31M |
| September 30, 2020 | -10.65M |
| June 30, 2020 | -11.16M |
| March 31, 2020 | -3.310M |
| December 31, 2019 | -8.986M |
| September 30, 2019 | -3.390M |
| June 30, 2019 | -3.584M |
| March 31, 2019 | -6.708M |
| June 30, 2018 | -5.396M |
| June 30, 2017 | -2.247M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 27.48M |
| Total Expenses (Quarterly) | 33.32M |
| EPS Diluted (Quarterly) | -0.0236 |
| Enterprise Value | 830.34M |
| Gross Profit Margin (Quarterly) | 80.94% |
| Profit Margin (Quarterly) | -21.24% |
| Earnings Yield | -0.03% |
| Normalized Earnings Yield | -0.0744 |